CRONCOX's clinical and data management teams bring focused expertise across the therapeutic areas where modern science is moving fastest. Every project benefits from indication-specific protocol experience.
Solid tumors, hematologic malignancies, immuno-oncology, CAR-T therapies, targeted therapies, and supportive care studies.
Heart failure, hypertension, arrhythmias, lipid management, anticoagulation, and structural heart disease.
Alzheimer's, Parkinson's, multiple sclerosis, epilepsy, depression, schizophrenia, and migraine.
Antivirals, antibiotics, antifungals, vaccines, HIV/AIDS, hepatitis, and pandemic preparedness.
Type 1 & 2 diabetes, obesity, thyroid disorders, growth hormone, and metabolic syndromes.
Asthma, COPD, pulmonary fibrosis, cystic fibrosis, and severe respiratory infections.
Rheumatoid arthritis, psoriasis, IBD, lupus, ankylosing spondylitis, and allergy disorders.
Orphan indications, pediatric rare diseases, genetic disorders, and ultra-rare patient registries.
Crohn's, ulcerative colitis, IBS, GERD, NASH/NAFLD, and pancreatic disorders.
Contraception, fertility, menopause, endometriosis, and obstetric & maternal health studies.
Age-related macular degeneration, diabetic retinopathy, glaucoma, dry eye, and gene therapies.
Prophylactic and therapeutic vaccines, biosimilars, monoclonal antibodies, and cell & gene therapies.